22 May 2015

Klaricid XL (Clarithromycin) - United Kingdom

ATC: J01FA
ANTIINFECTIVES FOR SYSTEMIC USE
ANTIBACTERIALS FOR SYSTEMIC USE
MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
MACROLIDES
Klaricid XL tablets

Generic Matches for Clarithromycin (3)
Klaricid Adult Sachet
Klaricid 500mg tablets
Klaricid Paediatric Suspension

Last Updated on 22 May 2015 by EPG Health Media Staff

Suggest content to an epgonline.org editor - or let us know about a mistake you have spotted on this page

Klaricid XL tablets Indication

Consideration should be given to official guidance on the appropriate use of antibacterial agents.

Klaricid XL 500 mg Tablets are indicated in adults and children 12 years and older.

Klaricid XL 500 mg Tablets is indicated for treatment of infections caused by susceptible organisms. Indications include:

Lower respiratory tract infections for example, acute and chronic bronchitis, and pneumonia.

Upper respiratory tract infections for example, sinusitis and pharyngitis.

Klaricid XL 500 mg Tablets is also indicated in skin and soft tissue infections of mild to moderate severity, for example folliculitis, cellulitis and erysipelas.

 

Klaricid XL tablets Generic Name

Clarithromycin

Type

POM

Summary Product Characteristics (SPCs) Links
SPC - Klaricid XL 500 mg Tablets (external site)

Related Learning Zones

CLL Knowledge Centre and CME

CLL Knowledge Centre and CME

The Chronic Lymphocytic Leukaemia (CLL) Knowledge Centre contains useful information arranged within four main sections: ‘Disease Awareness’, ‘Events’, ‘Resources’, and 'CME'. Healthcare professionals will find information on pathophysiology, signs and symptoms of CLL, diagnosis, prognosis, treatment and management options, an upcoming events calendar and an external links listing,

The CME activity ‘Treatment Optimisation in Chronic Lymphocytic Leukaemia’ has been EACCME-accredited and awarded 1 CME credit. Test your knowledge by answering quiz questions based on patient case study scenarios.

Prostate Cancer Learning Hub

Prostate Cancer Learning Hub

The Prostate Cancer Learning Hub has been designed with the busy healthcare professional in mind. The resource conveniently organises a range of up-to-date education content, reference materials and decision support tools, all focussing on prostate cancer. The disease awareness section provides you with access to a Prostate Cancer Knowledge Centre, which has been developed to provide you with easy to digest best practice guidance for the treatment and management of patients with prostate cancer.

Klaricid XL Marketing Information

Klaricid XL Generic Name
Clarithromycin
Marketing Company
Abbott Laboratories Limited
Drug Type
POM
Date of Issue, Marketing Authority 01/12/1996

Related Drugs - Infectious Diseases

Back to top